Visalytics
Visalytics
approved EB-2 (NIW) RFE Issued

Principal Investigator

Oncology · China · 2022-04-13

Processing Time
562 days
Decision Date
2022-04-13
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to apply CRISPR and exosome encapsulation techniques to regulate genes that target leukemia. This work focuses on discovering novel therapeutic targets for acute lymphoblastic leukemia to aid in the global fight against cancer.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The petitioner's work on early cancer detection and leukemia therapeutics has clear practical value for oncology and public health.

2 Well-positioned to Advance the Endeavor Met

With 8 years of experience, a strong publication record, and 120 citations, the petitioner is recognized as an expert in her field.

3 Waiver of Job Offer and Labor Certification Met

The urgency of cancer research and the petitioner's unique expertise make it beneficial to the U.S. to waive the labor certification.

Why This Petition Was Approved

The case was approved based on the petitioner's 15 peer-reviewed journal articles (3 first-authored) and 120 citations. Evidence included 4 expert recommendation letters, 4 instances of peer review for magazines, and funding from the National Natural Science Foundation of China. These metrics satisfied the Dhanasar prongs by demonstrating the national importance and recognized value of her oncology research.

Request for Evidence (RFE)

Successfully Addressed

An RFE was issued by the adjudication panel, which the legal team addressed by reinforcing the evidence of the petitioner's impact on oncology and the national importance of her leukemia research.

RFE Targets
prong 1 national importanceprong 2 well positionedprong 3 waiver benefit

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Judging Experience
Original Contributions

Similar Cases

Scientist

Healthcare · Bangladesh

WeGreened EB-2 (NIW) approved
Japan 126 days 2022-04-15
The petitioner proposes to continue her research on investigating the pathways that regulate healthy and cancerous cells. This work aims to develop new therapeutic drugs and organ transplant technologies, specifically focusing on identifying genetic markers associated with cancerous cell growth and proliferation.
View Case

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Massachusetts 111 days 2023-03-23
The petitioner proposes to continue her research in biomedical sciences, specifically optimizing therapeutic strategies for acute myeloid leukemia by elucidating molecular mechanisms. Her work focuses on identifying leukemia stem cell markers and critical transcription factors to develop advanced treatment strategies for therapy-resistant quiescent stem cells in blood cancer.
View Case

Postdoctoral Researcher

Biotechnology · Vietnam

WeGreened EB-2 (NIW) approved
Pennsylvania 103 days 2023-05-26
The petitioner proposes to introduce, evaluate, and refine innovative precision therapies to improve the treatment of leukemia and other blood cancers. This work focuses on developing targeted medical interventions to enhance clinical outcomes for patients with hematologic malignancies.
View Case

Assistant Professor

Healthcare · China

WeGreened EB-2 (NIW) approved
Pennsylvania 40 days 2025-05-13
The petitioner proposes to enhance CAR-T cell therapy for hematological malignancies by integrating laboratory research with patient-centered clinical trials. The work focuses on closing the translational gap to bring immunotherapy discoveries into clinical practice for leukemia and other blood cancers. The goal is to develop therapies that are more precise, responsive, and accessible to patients.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-13.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 562 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist